Increased apoptosis in metastatic human colonic adenocarcinomas

Cancer Biology and Therapy

Volumn 1, Issue 1, 2002, Pages 58-63

  Termuhlen, Paula M ^a   Sweeney Gotsch, Bridget M ^a   Berman, Russell S ^a   Ellis, Lee M ^a   Bucana, Corazon ^a   Shen, Yu ^a   Cleary, Karen R ^a   McConkey, David J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; FAS ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROTEIN BCL 2; STAUROSPORINE; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR PROTEIN;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; COLON TUMOR; COMPARATIVE STUDY; DRUG EFFECT; DRUG RESISTANCE; HUMAN; IMMUNOLOGY; LIVER TUMOR; METASTASIS; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENES, BCL-2; HUMANS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; STAUROSPORINE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036043771     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.1.43     Document Type: Article

References (31)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999 [see comments]. CA Cancer J Clin 1999; 49:8-31.
2. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68:251-305.
3. Potten CS. Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature 1977; 269:518-521. (Pubitemid 8245145)
4. Hayashi R, Luk H, Horio D, et al. Inhibition of apoptosis in colon tumors induced in the rat by 2-amino-3-methylimidazo[4,5-f ]quinoline. Cancer Res 1996; 56:4307-4310.
5. Bedi A, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55:1811-1816.
6. Weil M, et al. Constitutive expression of the machinery for programmed cell death. J Cell Biol 1996; 133:1053-1059. (Pubitemid 26172510)
7. Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 1991; 139:271-279.
8. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
9. Hashimoto S, Koji T, Kohara N, et al. Frequency of apoptosis relates inversely to invasiveness and metastatic activity in human colorectal cancer. Virchows Archiv 1997; 431:241-248. (Pubitemid 27470621)
10. Evan GI, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69:119-128.
11. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age [see comments]. Cell 1994; 79:573-582.
12. He TC, et al. Identification of c-MYC as a target of the APC pathway [see comments]. Science 1998; 281:1509-1512.
13. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398:422-426. (Pubitemid 29180374)
14. Morin PJ, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC [see comments]. Science 1997; 275:1787-1790. (Pubitemid 27136715)
15. Korinek V, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma [see comments]. Science 1997; 275:1784-1787. (Pubitemid 27136714)
16. Harrington EA, Bennett MR, Fanidi A, et al. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. Embo J 1994; 13:3286-3295. (Pubitemid 24226943)
17. Kastrinakis WV, et al. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 1995; 11:647-652.
18. Shiraki K, Tsuji N, Shioda T, et al. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas. Proc Natl Acad Sci USA 1997; 94:6420-6425.
19. Ogasawara J, et al. Lethal effect of anti-Fas antibody in mice. Nature 1993; 364, 806-809. (Pubitemid 23261761)
20. O'Connell J, O'Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184:1075-1082.
21. McDonnell TJ, et al. Expression of the protooncogene Bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52:6940-6944.
22. McConkey DJ, Greene G, Pettaway CA. Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res 1996.
23. Agui T, McConkey DJ, Tanigawa N. Comparative study of various biological parameters, including expression of surviving, between primary and metastatic human colonic adenocarcinomas. Am J Pathol Submitted 2000.
24. Flohil CC, Janssen PA Bosman FT. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon. J Pathol 1996; 178:393-397.
25. Kikuchi Y, Dinjens WN, Bosman FT. Proliferation and apoptosis in proliferative lesions of the colon and rectum. Virchows Archiv 1997; 431:111-117. (Pubitemid 27393841)
26. Krajewska M, et al. Elevated expression of BCL-X and reduced BAK in primary colorectal adenocarcinomas. Cancer Res 1996; 56:2422-2427. (Pubitemid 26154093)
27. Sinacrope FA, et al. Increased apoptosis accompanies neoplastic development in the human colorectum. Clin Cancer Res 1996; 2:1999-2006.
28. Zhang GJ, et al. Correlation between the expression of apoptosis-related Bcl-2 and p53 proteins and the carcinogenesis and progression of breast carcinomas. Clin Cancer Res 1997; 3:2329-2335.
29. Miyashita T, Harigai M, Hanada M, et al. Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res 1994; 54:3131-3135. (Pubitemid 24208916)
30. Marin MC, et al. Evidence that p53 and Bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 1994; 11:3107-3112.
31. Shao RG, et al. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function. Cancer Res 1997; 57:4029-4035.